1/70
A set of 70 vocabulary practice flashcards covering respiratory anatomy, pulmonary function testing, respiratory failure, asthma, COPD, bronchiectasis, cystic fibrosis, interstitial lung disease, pneumoconiosis, thoracic malignancies, pulmonary infections, thromboembolism, pleural disorders, tuberculosis, pulmonary hypertension, OSAHS, and ARDS.
Proximal Conductive Airways
The non-respiratory portion of the respiratory tract (including the nose, pharynx, larynx, trachea, bronchi, and terminal bronchioles) lined by pseudostratified columnar ciliated epithelium rich in goblet cells, cartilage, and smooth muscles, supplied by the systemic circulation.
Type II Pneumocytes
Granulated alveolar epithelial cells responsible for synthesizing and secreting pulmonary surfactant to reduce alveolar surface tension and prevent atelectasis.
Residual Volume (RV)
The volume of air remaining in the lungs after forceful maximal expiration; measured via plethysmography, it normally constitutes 20%−25% of total lung capacity but increases in air trapping.
Total Lung Capacity (TLC)
The total volume of air contained within the lungs following maximal inspiration, calculated as the sum of residual volume and vital capacity (TLC=RV+VC) via plethysmography.
FEV1/FVC Ratio
The proportion of forced vital capacity exhaled within the first second; normally 75%−80%, where a value <70% denotes obstructive ventilatory defect and a value ge70% (or normal/increased) denotes restrictive ventilatory defect.
Diffusing Capacity for Carbon Monoxide (DLCO)
A pulmonary function test measuring gas transfer across the alveolar-capillary membrane using a single breath of 0.3% carbon monoxide held for 10 seconds; depends on surface area, membrane thickness, capillary blood volume, and hemoglobin.
Type I Respiratory Failure
Hypoxemic respiratory failure defined as PaO2<60mmHg with a normal or low PaCO2 (<50mmHg), resulting from conditions like acute asthma, pulmonary edema, pneumonia, pneumothorax, pulmonary embolism, ARDS, and early ILD.
Type II Respiratory Failure
Hypercapnic respiratory failure defined as PaO2<60mmHg accompanied by elevated PaCO2>50mmHg, caused by alveolar hypoventilation due to central respiratory depression, neuromuscular disorders, chronic bronchitis, or respiratory muscle fatigue.
Asterixis
A coarse, bilateral flapping tremor elicited on wrist dorsiflexion, seen clinically in acute or severe hypercapnia (Type II respiratory failure) secondary to carbon dioxide retention and cerebral vasodilation.
Bronchial Asthma
A chronic inflammatory airway disease characterized by bronchial hyper-responsiveness to various stimuli and episodic, reversible lower airway narrowing presenting clinically with dyspnea, wheeze, cough, and chest tightness.
Extrinsic Asthma
Atopic asthma occurring typically in childhood (males > females), driven by IgE-mediated allergic mechanisms, positive family history of atopy, elevated eosinophils, positive skin-prick tests, and a tendency to remit by teenage years.
Intrinsic Asthma
Late-onset, non-atopic asthma typically developing in middle-aged females without family history of atopy, characterized by normal IgE, negative skin-prick tests, persistence, and frequent steroid dependency.
Samter's Triad (Widal's Syndrome)
A clinical complex comprising rhinosinusitis, recurrent nasal polyposis, and bronchial asthma exacerbated by aspirin and NSAIDs due to selective inhibition of cyclooxygenase and shifting of arachidonic acid metabolism to the lipoxygenase pathway.
Fractional Exhaled Nitric Oxide (FeNO)
A non-invasive biomarker measuring the fraction of nitric oxide in exhaled breath to quantify eosinophilic airway inflammation; elevated levels support the diagnosis of asthma and predict responsiveness to inhaled corticosteroids.
Severe Asthma Exacerbation
An acute exacerbation of asthma diagnosed by the presence of any of: PEFR33%−50%, respiratory rate >25/min, heart rate >110/bpm, or inability to complete a full sentence in one breath.
Life-Threatening Asthma
An acute asthma crisis characterized by any one of: PEFR<33%, silent chest, cyanosis, bradycardia, hypotension, exhaustion, confusion, coma, or an arterial blood gas showing normal or rising PaCO2.
Near-Fatal Asthma
A critical, decompensated asthma presentation defined by respiratory acidosis and hypercapnia (↑PaCO2), requiring immediate intensive care unit admission and invasive mechanical ventilation.
Chronic Obstructive Pulmonary Disease (COPD)
A preventable and treatable lung condition characterized by persistent, progressive, and fixed airflow limitation (FEV1/FVC<70% post-bronchodilator) caused by significant airway and alveolar destruction from exposure to noxious particles or gases.
Chronic Bronchitis
A clinical condition defined by the presence of a chronic cough productive of sputum for at least 3 consecutive months in each of 2 consecutive years, in the absence of other explanatory pulmonary or cardiac diseases.
Emphysema
A pathological diagnosis characterized by abnormal, permanent enlargement of the respiratory airspaces distal to the terminal bronchioles accompanied by destruction of alveolar walls without obvious fibrosis.
Alpha-1-Antitrypsin Deficiency
An autosomal recessive genetic disorder causing deficient circulating serum antiprotease levels, leading to uninhibited neutrophil elastase activity, panacinar emphysema predominantly in the upper lobes, and hepatic cirrhosis in patients <40 years.
Pink Puffer
A clinical phenotype of severe emphysema describing a thin, hyperventilating patient who maintains near-normal arterial blood gases without early cyanosis or cor pulmonale by expending significant muscular effort to breathe.
Blue Bloater
A clinical phenotype of chronic bronchitis describing an overweight, cyanotic patient who tolerates hypoxemia and hypercapnia, predisposing them to early secondary polycythemia, pulmonary hypertension, and right ventricular failure.
BODE Index
A multidimensional grading tool used to assess prognosis in COPD incorporating Body mass index, Obstruction (FEV1), Dyspnea score, and Exercise capacity (6-minute walk distance); scores of 7−10 confer an 82% 4-year mortality.
Long-Term Oxygen Therapy (LTOT)
Continuous oxygen therapy administered for at least 15 hours/day to achieve a PaO2>60mmHg (SaO2≥90%), indicated in stable nonsmoking COPD patients with PaO2<55mmHg or 55−60mmHg with cor pulmonale or hematocrit >55%.
Cor Pulmonale
Right ventricular hypertrophy, dilation, and potential right heart failure developing secondary to chronic pulmonary arterial hypertension caused by disorders of the lung parenchyma or pulmonary vasculature.
Bronchiectasis
An abnormal, irreversible chronic dilatation of one or more bronchi associated with recurrent transmural infection, chronic necrotizing airway inflammation, and impaired mucociliary clearance.
Kartagener's Syndrome
A congenital primary ciliary dyskinesia subtype inherited in an autosomal recessive fashion, defined by the clinical triad of bronchiectasis, chronic paranasal sinusitis, and situs inversus/dextrocardia.
Young's Syndrome
A triad of bronchiectasis, chronic sinusitis, and obstructive azoospermia in men who maintain structurally normal cilia and normal spermatogenesis.
Cystic Fibrosis
The most common lethal autosomal recessive disorder among Caucasians, caused by mutations in the CFTR gene on chromosome 7 resulting in defective epithelial chloride transport and thick, inspissated multiorgan secretions.
CFTR Protein
Cystic Fibrosis Transmembrane Conductance Regulator; an epithelial apical cAMP-dependent chloride channel whose malfunction leads to intracellular chloride retention, excessive sodium and water reabsorption, and dehydration of mucosal secretions.
Sweat Test
The gold standard diagnostic test for cystic fibrosis measuring sweat electrolytes via pilocarpine iontophoresis, where sodium and chloride concentrations >60mmol/L are confirmatory.
Diffuse Parenchymal Lung Disease (DPLD / ILD)
A diverse group of over 200 chronic conditions affecting the pulmonary interstitium, characterized pathologically by alveolo-capillary inflammation or fibrosis, exertional dyspnea, restrictive spirometry, and reduced DLCO.
Idiopathic Pulmonary Fibrosis (IPF)
A chronic, progressive fibrosing interstitial pneumonia of unknown etiology occurring mainly in smokers aged >50 years, defined radiologically and pathologically by a Usual Interstitial Pneumonia (UIP) pattern with median survival of 3 years.
Hamman-Rich Syndrome
An acute, fulminant presentation of idiopathic interstitial pneumonia (acute interstitial pneumonia) characterized by rapid clinical deterioration and development of fatal respiratory failure within months.
Sarcoidosis
A multisystem granulomatous disorder of unknown etiology pathologically defined by the formation of non-caseating epithelioid granulomas, predominantly involving bilateral hilar lymph nodes and lung parenchyma in young adults.
Löfgren's Syndrome
An acute, self-limiting form of sarcoidosis characterized by the clinical triad of bilateral hilar lymphadenopathy (BHL), erythema nodosum, and acute arthritis or periarthritis, carrying an excellent prognosis.
Heerfordt's Syndrome (Uveoparotid Fever)
A specific presentation of acute sarcoidosis characterized by bilateral parotid gland enlargement, prolonged fever, anterior uveitis, and cranial facial nerve (VII) palsy.
Lupus Pernio
Indurated, violaceous, blue-purple raised cutaneous lesions on the nose, cheeks, ears, and digits, pathognomonic for chronic fibrotic sarcoidosis and associated with upper respiratory tract involvement.
Pneumoconiosis
A group of occupational lung disorders caused by chronic inhalation, pulmonary accumulation, and tissue reaction to inorganic mineral dusts, categorized into fibrogenic (silica, asbestos) and inert forms.
Caplan Syndrome
The development of multiple rounded, peripheral pulmonary nodules measuring 0.5−5cm on chest radiography in patients with concurrent rheumatoid arthritis and inorganic dust exposure (coal, silica, asbestos).
Progressive Massive Fibrosis (PMF)
A severe, disabling complication of coal worker's pneumoconiosis or silicosis characterized by large confluent masses (>1cm) in the upper lung lobes that can cavitate, cause melanoptysis, and reduce DLCO.
Silicosis
A fibrogenic pneumoconiosis triggered by inhalation of crystalline silicon dioxide (quartz), cytotoxic to alveolar macrophages and characterized radiologically by upper/mid-zone nodules and egg-shell hilar calcification.
Egg-Shell Calcification
A classic radiologic sign on chest radiography and CT marked by thin, circumferential peripheral rim calcification of enlarged hilar and mediastinal lymph nodes, highly indicative of silicosis.
Asbestosis
Diffuse interstitial pulmonary fibrosis caused by chronic occupational inhalation of asbestos mineral fibers, typically affecting the lower lung zones and manifesting with bilateral basal crackles and digital clubbing in 40% of cases.
Pleural Plaques
Well-circumscribed, fibrocalcific lesions on the parietal pleura following asbestos exposure that serve as an objective marker of exposure without risk of malignant transformation.
Malignant Mesothelioma
A highly lethal primary neoplasm of the pleura or peritoneum strongly linked to prior asbestos exposure (even at low levels), featuring a latency of several decades and poor survival (10−16 months).
Extrinsic Allergic Alveolitis (Hypersensitivity Pneumonitis)
A diffuse immunologically mediated lung disease (Types III and IV hypersensitivity) caused by repeated inhalation of organic antigens (e.g., bird proteins, thermophilic actinomycetes), characterized by bronchoalveolar lymphocytosis with CD8+ predominance.
Pancoast's Syndrome
A clinical constellation resulting from apical bronchogenic carcinoma invading the lower brachial plexus (C8−T1), cervical sympathetic chain, and adjacent chest wall, causing shoulder pain, hand muscle wasting, and Horner's syndrome.
Horner's Syndrome
A neurologic triad of unilateral ptosis, miosis, and facial anhidrosis produced by compression or infiltration of the cervical sympathetic chain, often by an apical thoracic malignancy.
Hypertrophic Pulmonary Osteoarthropathy (HPOA)
A paraneoplastic syndrome associated predominantly with non-small cell lung carcinoma (squamous cell and adenocarcinoma), manifesting as painful periostitis of distal long bones, symmetrical arthritis, and digital clubbing.
Small-Cell Lung Carcinoma (SCLC)
An aggressive, poorly differentiated high-grade neuroendocrine bronchogenic carcinoma accounting for 20% of lung cancers, strongly associated with smoking, early systemic metastasis, and endocrine paraneoplastic syndromes (SIADH, ectopic ACTH).
Community-Acquired Pneumonia (CAP)
An acute infection of the lung parenchyma acquired in the community or diagnosed within 48 hours of hospital admission, commonly caused by Streptococcus pneumoniae and presenting with cough, fever, dyspnea, and consolidation.
CURB-65 Score
A clinical stratification tool predicting 30-day mortality in CAP allocating 1 point each for Confusion, Urea >7mmol/L, Respiratory rate ≥30/min, Blood pressure (SBP<90mmHg or DBP≤60mmHg), and Age ≥65 years.
Hospital-Acquired Pneumonia (HAP)
A bacterial parenchymal lung infection presenting ≥48 hours (≥2 days) after hospital admission that was not incubating upon initial entry, frequently caused by Pseudomonas aeruginosa, MRSA, and Klebsiella pneumoniae.
Aspiration Pneumonia
Pulmonary parenchymal inflammation and secondary infection caused by the abnormal inhalation of colonized gastric or oropharyngeal secretions into dependent lung zones (posterior segment of upper lobes, apical segment of lower lobes).
Pneumocystis jirovecii Pneumonia (PCP)
An opportunistic atypical fungal pneumonia occurring in severely immunocompromised individuals (e.g., AIDS with CD4<200/μL), featuring exertional hypoxemia, bilateral perihilar ground-glass opacities, and high response to high-dose co-trimoxazole.
Pulmonary Hydatid Disease
A zoonotic pulmonary parasitic infestation caused by the larval stage of the tapeworm Echinococcus granulosus, producing spherical hydatid fluid cysts classically demonstrating a water-lily sign or hydatidoptysis.
Massive Pulmonary Embolism
An acute thromboembolic obstruction involving >50% of the pulmonary vascular tree that induces acute right ventricular overload, cardiogenic shock, and sustained arterial hypotension (SBP<90mmHg).
Westermark's Sign
A specific radiographic sign of acute pulmonary embolism marked by localized area of hyperlucency and oligemia due to mechanical vascular obstruction in distal lung fields.
Hampton's Hump
A radiographic peripheral, wedge-shaped consolidation abutting the pleural surface with its apex directed toward the pulmonary hilum, signifying ischemic pulmonary infarction following a pulmonary embolus.
Palla's Sign
An abnormal radiological dilation and enlargement of the right descending descending pulmonary artery visible on a frontal chest radiograph in patients with acute pulmonary embolism.
S1Q3T3 Pattern
An electrocardiographic sign of acute cor pulmonale and right heart strain in massive pulmonary embolism, featuring a deep S wave in lead I, an abnormal Q wave in lead III, and an inverted T wave in lead III.
Spontaneous Pneumothorax Subtypes
The three recognized pathological mechanisms of spontaneous pleural air leak: Closed type (pleural leak seals, negative mean pleural pressure maintained), Open type (persistent defect, atmospheric mean pleural pressure), and Tension type (one-way valve causing positive mean pleural pressure and contralateral mediastinal shift).

Tension Pneumothorax
A critical emergency where a unilocular one-way flap valve allows air to enter the pleural space on inspiration without exit, generating positive intrapleural pressure, severe hypoxia, contralateral tracheal deviation, and obstructive shock.
Light's Criteria
A diagnostic biochemical rule defining an exudative pleural effusion if at least one criterion is satisfied: Pleural:Serum protein ratio >0.5, Pleural:Serum LDH ratio >0.6, or Pleural LDH >2/3 the upper reference limit of normal serum LDH.
Empyema
The accumulation of macroscopic pus or an infected exudative collection within the pleural cavity, defined biochemically by high neutrophilia, positive microbiology, pleural fluid pH<7.2, glucose <60mg/dL, and LDH>1000IU/L.
Ranke Complex
A healed primary tuberculosis manifestation comprising a calcified subpleural pulmonary parenchymal granuloma (Ghon focus) combined with ipsilateral calcified hilar lymph nodes.
Miliary Tuberculosis
An acute, disseminated hematogenous spread of Mycobacterium tuberculosis producing widespread, minute (1−2mm) yellowish non-caseating and caseating lesions resembling millet seeds across multiple organs.
Obstructive Sleep Apnoea/Hypopnoea Syndrome (OSAHS)
A nocturnal breathing disorder characterized by recurrent collapse of the pharyngeal airway during sleep leading to sleep fragmentation, daytime somnolence, and an Apnoea-Hypopnoea Index (AHI≥5/hour).
Acute Respiratory Distress Syndrome (ARDS)
A form of non-cardiogenic pulmonary permeability edema triggered by diffuse alveolar epithelial and capillary endothelial damage, characterized by refractory hypoxemia (PaO2/FiO2≤300mmHg with PEEP \ge 5\,\text{cm H_2O}), bilateral infiltrates, and intra-alveolar hyaline membranes.